Cargando…

Blood Levels of Glutamate and Glutamine in Recent Onset and Chronic Schizophrenia

Converging evidence indicates that dysfunctions in glutamatergic neurotransmission and in the glutamate-glutamine cycle play a role in the pathophysiology of schizophrenia. Here, we investigated glutamate and glutamine levels in the blood of patients with recent onset schizophrenia or chronic schizo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madeira, Caroline, Alheira, Flavio V., Calcia, Marilia A., Silva, Thuany C. S., Tannos, Filippe M., Vargas-Lopes, Charles, Fisher, Melissa, Goldenstein, Nelson, Brasil, Marco Antonio, Vinogradov, Sophia, Ferreira, Sergio T., Panizzutti, Rogerio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305751/ https://www.ncbi.nlm.nih.gov/pubmed/30618883 http://dx.doi.org/10.3389/fpsyt.2018.00713

Ejemplares similares

Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
por: Madeira, Caroline, et al.
Publicado: (2018)

Risk-Conferring Glutamatergic Genes and Brain Glutamate Plus Glutamine in Schizophrenia
por: Bustillo, Juan R., et al.
Publicado: (2017)

Dysregulated noradrenergic response is associated with symptom severity in individuals with schizophrenia
por: Pelegrino, Ana, et al.
Publicado: (2023)

Increased Glutamate Plus Glutamine in the Right Middle Cingulate in Early Schizophrenia but Not in Bipolar Psychosis: A Whole Brain (1)H-MRS Study
por: Bustillo, Juan R., et al.
Publicado: (2021)

Astrocytic Regulation of Glutamate Transmission in Schizophrenia
por: Mei, Yu-Ying, et al.
Publicado: (2018)

Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer
por: Guercio, Gerson D., et al.
Publicado: (2018)

MR-Spectroscopy of GABA and Glutamate/Glutamine Concentrations in Auditory Cortex in Clinical High-Risk for Psychosis Individuals
por: Grent-’t-Jong, Tineke, et al.
Publicado: (2022)

Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia
por: Kumar, Pooja, et al.
Publicado: (2021)

Magnetic Resonance Imaging in Studying Schizophrenia, Negative Symptoms, and the Glutamate System
por: Gruber, Oliver, et al.
Publicado: (2014)

Commentary: Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia
por: Khan, Tauseef A., et al.
Publicado: (2021)

Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia
por: de Bartolomeis, Andrea, et al.
Publicado: (2020)

Age-related changes in prepulse inhibition of the startle response
por: de Oliveira, Yasmin Guedes, et al.
Publicado: (2023)

Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal (1)H-MRS Studies
por: Egerton, Alice, et al.
Publicado: (2017)

The association between language-based task-functional magnetic resonance imaging hemodynamics and baseline GABA+ and glutamate–glutamine measured in pre-supplementary motor area: A pilot study in an aging model
por: Krishnamurthy, Lisa C., et al.
Publicado: (2022)

The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice
por: Zheng, Peng, et al.
Publicado: (2019)

A Longitudinal Multimodal Neuroimaging Study to Examine Relationships Between Resting State Glutamate and Task Related BOLD Response in Schizophrenia
por: Cadena, Elyse J., et al.
Publicado: (2018)

Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients
por: Li, Jinguang, et al.
Publicado: (2020)

Ketamine Alters Functional Gamma and Theta Resting-State Connectivity in Healthy Humans: Implications for Schizophrenia Treatment Targeting the Glutamate System
por: Curic, Stjepan, et al.
Publicado: (2021)

Reduced Activity in an Inpatient Liaison Psychiatry Service During the First Wave of the COVID-19 Pandemic: Comparison With 2019 Data and Characterization of the SARS-CoV-2 Positive Cohort
por: Butler, Matthew, et al.
Publicado: (2021)

Modeling the glutamate–glutamine neurotransmitter cycle
por: Shen, Jun
Publicado: (2013)

Glutamine and glutamate supplementation raise milk glutamine concentrations in lactating gilts
por: Manso, Helena Emilia CCC, et al.
Publicado: (2012)

Increased Absolute Glutamate Concentrations and Glutamate-to-Creatine Ratios in Patients With Methamphetamine Use Disorders
por: Yang, Wenhan, et al.
Publicado: (2018)

Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology
por: Nasir, Madeeha, et al.
Publicado: (2020)

Glutamine Uptake via SNAT6 and Caveolin Regulates Glutamine–Glutamate Cycle
por: Gandasi, Nikhil R., et al.
Publicado: (2021)

Variants in the zinc transporter-3 encoding gene (SLC30A3) in schizophrenia and bipolar disorder: Effects on brain glutamate–A pilot study
por: Jelen, Luke A., et al.
Publicado: (2022)

Increased thalamic glutamate/glutamine levels in migraineurs
por: Bathel, Adina, et al.
Publicado: (2018)

Glutamine and glutamate: Nonessential or essential amino acids?
por: Watford, Malcolm
Publicado: (2015)

Disembodied Language in Early-Onset Schizophrenia
por: Zakowicz, Przemysław, et al.
Publicado: (2022)

Specificity and Durability of Changes in Auditory Processing Efficiency After Targeted Cognitive Training in Individuals With Recent-Onset Psychosis
por: Biagianti, Bruno, et al.
Publicado: (2020)

Early-Onset Schizophrenia Showed Similar but More Severe Olfactory Identification Impairment Than Adult-Onset Schizophrenia
por: Li, Ze-tian, et al.
Publicado: (2020)

Imaging Habenula Volume in Schizophrenia and Bipolar Disorder
por: Schafer, Matthew, et al.
Publicado: (2018)

Deficits in Auditory and Visual Sensory Discrimination Reflect a Genetic Liability for Psychosis and Predict Disruptions in Global Cognitive Functioning
por: Ramsay, Ian S., et al.
Publicado: (2020)

Lower Ventromedial Prefrontal Cortex Glutamate Levels in Patients With Obsessive–Compulsive Disorder
por: Batistuzzo, Marcelo C., et al.
Publicado: (2021)

Case series: Cariprazine in early-onset schizophrenia
por: Ivanova, Elena, et al.
Publicado: (2023)

Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Neurological Abnormalities in Recent-Onset Schizophrenia and Asperger-Syndrome
por: Hirjak, Dusan, et al.
Publicado: (2014)

Abnormal Brain Structure Morphology in Early-Onset Schizophrenia
por: Cai, Jia, et al.
Publicado: (2022)

Crossroad between current knowledge and new perspective of diagnostic and therapy of late-onset schizophrenia and very late-onset schizophrenia-like psychosis: An update
por: Stȩpień-Wyrobiec, Olga, et al.
Publicado: (2022)

Glutamate and asparagine cataplerosis underlie glutamine addiction in melanoma
por: Ratnikov, Boris, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_14dfegi5713vo994j10hc6ov92